Medicine pack check sheet

Source-linked reading points

• 24 mg/26 mg, 49 mg/51 mg and 97 mg/103 mg state the labelled amounts of two ingredients: sacubitril and valsartan. Neither one number, a total milligram number nor the number on another valsartan product is a basis for self-combining, halving or substituting.
• The U.S. label lists film-coated tablets separately from ENTRESTO SPRINKLE oral pellets. Pellet packaging states that the capsule shell is opened for administration and the pellets are not swallowed whole, chewed or crushed; that does not establish the same handling for the film-coated tablet. Any splitting, crushing, opening or dosage-form switch must be confirmed from the current label for the exact product and a pharmacist.
• The label identifies important checks involving ACE inhibitors, other ARBs, potassium supplements/salt substitutes, potassium-sparing diuretics, NSAIDs and lithium. With blood-pressure, heart-failure, diuretic, pain or supplement products, have a clinician or pharmacist review the complete medicine list and actual packs; do not self-add, stop or substitute based on similar names.
• The label contains explicit restrictions for switching with ACE inhibitors and for some prior reactions, as well as pregnancy-related warnings. This page does not turn those label requirements into an individual transition schedule or treatment decision; starting, stopping, switching, missed doses or any new concern must be addressed with the prescribing team, pharmacist and current target-market label.